AAAAAA

   
Results: 1-3 |
Results: 3
Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients
Authors: Penson, MG Fricker, FJ Thompson, JR Harker, K Williams, BJ Kahler, DA Schowengerdt, KO
Citation: Mg. Penson et al., Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients, J HEART LUN, 20(6), 2001, pp. 611-618
Increased expression of the lymphocyte early activation marker CD69 in peripheral blood correlates with histologic evidence of cardiac allograft rejection
Authors: Schowengerdt, KO Fricker, FJ Bahjat, KS Kuntz, ST
Citation: Ko. Schowengerdt et al., Increased expression of the lymphocyte early activation marker CD69 in peripheral blood correlates with histologic evidence of cardiac allograft rejection, TRANSPLANT, 69(10), 2000, pp. 2102-2107
Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients
Authors: Penson, MG Winter, WE Fricker, FJ Harker, K Kahler, DA Kubilis, PS Schowengerdt, KO
Citation: Mg. Penson et al., Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients, J HEART LUN, 18(7), 1999, pp. 707-713
Risultati: 1-3 |